In animal studies spanning three decades, no lethal dose has been identified
Preclinical studies have suggested potential biomarkers such as circulating free IGF levels, mutations of p53, BRCA1, KRAS and BRAF, IRS2 copy number gain, InsR/IGF-IR overexpression, InsR/IGF-IR pathway activation, PTEN loss, CD24, mesenchymal markers, -catenin/TCF activity, FUS-DDIT3 fusion, and ERG [192,193,194,195,196,197,198,199,200,201]
Frequently Asked Questions Is astaxanthin stronger than glutathione
Though these side effects are not officially listed on the drug's label, anecdotal evidence is building around depression, anxiety, and suicidal thoughts among users